The HEAL-IST IDE Trial is underway to evaluate the safety and effectiveness of a new approach called hybrid sinus node sparing ablation in patients with symptomatic inappropriate sinus tachycardia (IST).
Dr. Carlo de Asmundis explains the procedure and trial here: <a href="https://okt.to/xZ4Mb5" target="_blank">https://okt.to/xZ4Mb5</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=inappropriatesinustachy…; target='_blank'>#inappropriatesinustachycardia</a>
